Medicine: Vaccine Evidence

All week long, the casualty list among children inoculated with Salk vaccine kept going up, but fortunately the rate of climb was slowed. The U.S. Public Health Service got moving on its promised "re appraisal" of all vaccine so far finished by the manufacturers. By week's end the reappraisal teams were authorizing renewed release of vaccine, and inoculations could resume this week.

Clean Bill. First manufacturer to get a going-over was Detroit's Parke, Davis & Co. — largely, no doubt, because its vac cine so far had a spotless record and there was every reason to believe that the PHS would have...

Want the full story?

Subscribe Now

Subscribe
Subscribe

Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!